Media

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium

The advantages of frontotemporal degeneration drug development (Part 2 of frontotemporal degeneration: the next therapeutic frontier)

Global standardization measurement of cerebral spinal fluid for Alzheimer’s disease: an update from the Alzheimer’s Association Global Biomarkers Consortium

Critical Path Institute Names Martha Brumfield CEO

The Board of Directors of the Critical Path Institute (C-Path) announced today that Martha Brumfield, Ph.D., has been named interi

CFAST Announces Parkinson’s Disease Drug Development Milestone: Release and Availability of a PD Therapeutic Area Data Standard

March 1, 2013

Critical Path Institute’s Electronic Patient-Reported Outcome Consortium

March 1, 2013

The Patient-Reported Outcome (PRO) Consortium at the Critical Path Institute (C-Path)

January 1, 2013

Patient Reported Outcomes Newsletter-MAPI Research Trust

Understanding Placebo Responses in Alzheimer’s Disease Clinical Trials from the Literature Meta-Data and CAMD Database

Public-private partnerships as driving forces in the quest for innovative medicines

Previous9394 95...109 Next